| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AFRM | Class A Common Stock | Options Exercise | +3.33K | +15.15% | 25.3K | Nov 1, 2021 | Direct | F1 | ||
| transaction | AFRM | Class A Common Stock | Tax liability | -$223K | -1.46K | -5.78% | $152.66* | 23.9K | Nov 1, 2021 | Direct | F2 |
| transaction | AFRM | Class A Common Stock | Options Exercise | $620K | +115K | +481.82% | $5.39 | 139K | Nov 1, 2021 | Direct | |
| transaction | AFRM | Class A Common Stock | Sale | -$1.34M | -8.87K | -6.39% | $151.49* | 130K | Nov 1, 2021 | Direct | F3, F4 |
| transaction | AFRM | Class A Common Stock | Sale | -$5.33M | -35K | -26.93% | $152.26* | 95K | Nov 1, 2021 | Direct | F3, F5 |
| transaction | AFRM | Class A Common Stock | Sale | -$1.77M | -11.5K | -12.14% | $153.20* | 83.5K | Nov 1, 2021 | Direct | F3, F6 |
| transaction | AFRM | Class A Common Stock | Sale | -$3.93M | -25.4K | -30.49% | $154.30* | 58K | Nov 1, 2021 | Direct | F3, F7 |
| transaction | AFRM | Class A Common Stock | Sale | -$3.65M | -23.5K | -40.58% | $155.03* | 34.5K | Nov 1, 2021 | Direct | F3, F8 |
| transaction | AFRM | Class A Common Stock | Sale | -$391K | -2.5K | -7.25% | $156.41* | 32K | Nov 1, 2021 | Direct | F3, F9 |
| transaction | AFRM | Class A Common Stock | Sale | -$252K | -1.6K | -5.01% | $157.25* | 30.4K | Nov 1, 2021 | Direct | F3, F10 |
| transaction | AFRM | Class A Common Stock | Sale | -$477K | -3K | -9.88% | $159.09* | 27.4K | Nov 1, 2021 | Direct | F3, F11 |
| transaction | AFRM | Class A Common Stock | Sale | -$431K | -2.7K | -9.87% | $159.67* | 24.7K | Nov 1, 2021 | Direct | F3, F12 |
| transaction | AFRM | Class A Common Stock | Sale | -$130K | -800 | -3.24% | $162.91* | 23.9K | Nov 1, 2021 | Direct | F3, F13 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AFRM | Restricted Stock Units | Options Exercise | $0 | -3.33K | -6.67% | $0.00 | 46.7K | Nov 1, 2021 | Class A Common Stock | 3.33K | Direct | F1, F14 | |
| transaction | AFRM | Stock Option (Right to Buy) | Options Exercise | $0 | -115K | -8.09% | $0.00 | 1.31M | Nov 1, 2021 | Class A Common Stock | 115K | $5.39 | Direct | F15 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit (RSUs) represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| F2 | Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's RSUs that vested on November 1, 2021. |
| F3 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021. |
| F4 | Represents the weighted average sale price of the shares sold from $150.80 to $151.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | Represents the weighted average sale price of the shares sold from $151.81 to $152.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | Represents the weighted average sale price of the shares sold from $152.81 to $153.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | Represents the weighted average sale price of the shares sold from $153.81 to $154.80 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | Represents the weighted average sale price of the shares sold from $154.81 to $155.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | Represents the weighted average sale price of the shares sold from $155.98 to $156.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F10 | Represents the weighted average sale price of the shares sold from $156.98 to $157.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F11 | Represents the weighted average sale price of the shares sold from $158.46 to $159.42 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F12 | Represents the weighted average sale price of the shares sold from $159.46 to $160.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F13 | Represents the weighted average sale price of the shares sold from $162.85 to $163.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F14 | Restricted stock unit grant started vesting on January 1, 2021, and vests in equal monthly installments for a period of twenty-four months ending January 1, 2023, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. |
| F15 | Stock options vest with respect to 1/4 of the shares of the Issuer's Class A common stock, par value $0.00001 per share ("Class A Common Stock"), underlying the stock option on the one-year anniversary of August 27, 2018, the vesting commencement date, and the remaining 3/4 of the shares underlying the option vest in equal monthly installments over the subsequent three years, in each case subject to continued service with the Issuer. The Reporting Person can elect to exercise the stock options at any time, provided that the shares acquired upon exercise remain subject to the applicable vesting schedule. |